Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Glioblastoma
Data on glioblastoma reported by M.M. Zulkifli and co-researchers
April 22nd, 2009
"Newcastle disease virus ( NDV) is a virus of paramyxovirus family and lately has been studied for the treatment of cancer in human. In this study, we successfully determined the oncolysis potential of NDV vaccine, V4UPM tested on the human glioblastoma multiform cell line (DBTRG.05MG) and human glioblastoma astrocytoma cell line (U-87MG) in vitro and in vivo," scientists writing in the journal Neurological Research report. "The V4UPM strain is a modified V4 strain developed as thermostable feed pellet vaccine for poultry. The objectives of this study were mainly to evaluate the cytolytic effect and subsequently determine the brain tumor regression potential...
Source: Vaccine Weekly (2009-04-22)
|
